Zomedica Announces First Quarter 2019 Financial Results
10 mai 2019 17h21 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today...
Zomedica Announces Private Placement of Preferred Shares
10 mai 2019 06h00 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Announces 2018 Annual Meeting Results
15 août 2018 16h15 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results
09 août 2018 16h01 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results
11 mai 2017 16h15 HE
|
Zomedica
ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported...
Zomedica Announces Adoption of Advance Notice Bylaw
28 avr. 2017 16h15 HE
|
Zomedica
ANN ARBOR, Mich., April 28, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, announces...
Zomedica Raises C$4.35 Million in Second Tranche Closing of Equity Financing for Aggregate Proceeds of C$5.54 Million
10 avr. 2017 06h55 HE
|
Zomedica
ANN ARBOR, Mich., April 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company and health care solutions company, today announced the closing of...
Zomedica Retains Renmark Financial Communications to Enhance Investor Outreach and Extends Equity Offering
07 nov. 2016 19h03 HE
|
Zomedica
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ANN ARBOR, Mich., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM)...
Zomedica Announces Continuation of Aggregate C$15.0 Million Equity Financing
06 oct. 2016 18h00 HE
|
Zomedica
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESANN ARBOR, Mich., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a...
Zomedica Appoints Two Animal Health Veterans to Board of Directors
04 oct. 2016 06h55 HE
|
Zomedica
ANN ARBOR, Mich., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company, today announced it has appointed Jane Eagleson and Tom...